Search Results - "Nilsen, D W"

Combined analyses and extended follow‐up of two randomized controlled homocysteine‐lowering B‐vitamin trials by Ebbing, M., Bønaa, K. H., Arnesen, E., Ueland, P. M., Nordrehaug, J. E., Rasmussen, K., Njølstad, I., Nilsen, D. W., Refsum, H., Tverdal, A., Vollset, S. E., Schirmer, H., Bleie, Ø., Steigen, T., Midttun, Ø., Fredriksen, Å., Pedersen, E. R., Nygård, O.

“…  Ebbing M., Bønaa K.H., Arnesen E., Ueland P.M., Nordrehaug J.E., Rasmussen K., Njølstad I., Nilsen D.W., Refsum H., Tverdal A., Vollset S.E., Schirmer H.,…”
Get full text

Homocysteine‐lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease by Bleie, Ø., Semb, A. G., Grundt, H., Nordrehaug, J. E., Vollset, S. E., Ueland, P. M., Nilsen, D. W. T., Bakken, A. M., Refsum, H., Nygård, O. K.

“… Objectives.  A high level of total homocysteine (tHcy) is a risk marker for cardiovascular disease (CVD), and is related to inflammation. We wanted to test…”
Get full text

Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction by Aarsetøy, H, Valente, E, Reine, A, Mansoor, M.A, Grundt, H, Nilsen, D.W.T

“…Objective: To evaluate whether low levels of holotranscobalamin (holoTC) or elevated levels of methylmalonic acid (MMA), both indicators of vitamin B12…”
Get full text

Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction by GRUNDT, H, NILSEN, D. W. T, MANSOOR, M. A, NORDØY, A

“…To assess the oxidative burden of a highly concentrated compound of n-3 PUFAs as compared to corn oil by measuring thiobarbituric acid-malondialdehyde complex…”
Get full text

Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease by Bjørnestad, E. Ø., Olset, H., Dhar, I., Løland, K., Pedersen, E. K. R., Svingen, G. F. T., Svardal, A., Berge, R. K., Ueland, P. M., Tell, G. S., Nilsen, D. W. T., Nordrehaug, J. E., Nygaard, E., Nygård, O.

“…Background The carnitine precursor trimethyllysine (TML) is associated with progression of atherosclerosis, possibly through a relationship with…”
Get full text

Cosinor modelling of seasonal variation in 25-hydroxyvitamin D concentrations in cardiovascular patients in Norway by Degerud, E, Hoff, R, Nygård, O, Strand, E, Nilsen, D W, Nordrehaug, J E, Midttun, Ø, Ueland, P M, de Vogel, S, Dierkes, J

“…Background/Objectives: Seasonal variation may reduce the validity of 25-hydroxyvitamin D (25OHD) as a biomarker of vitamin D status. Here we aimed to identify…”
Get full text

Association of plasma neopterin with risk of an inpatient hospital diagnosis of atrial fibrillation: results from two prospective cohort studies by Zuo, H., Nygård, O., Ueland, P. M., Vollset, S. E., Svingen, G. F. T., Pedersen, E. R., Midttun, Ø., Meyer, K., Nordrehaug, J. E., Nilsen, D. W. T., Tell, G. S.

“…Background Link between inflammation and atrial fibrillation (AF) has been increasingly recognized. Neopterin, a biomarker of cellular immune activation, may…”
Get full text

Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia by Grundt, H, Nilsen, D W, Hetland, O, Mansoor, M A, Aarsland, T, Woie, L

“…Favourable effects of n-3 fatty acids on the atherogenic risk profile were recently demonstrated in subjects with combined (type IIb) hyperlipidaemia, not…”
Get more information

Characteristics and prognostic impact of plasma fibrin monomer (soluble fibrin) in patients with coronary artery disease by Hetland, Ø, Knudsen, A, Dickstein, K, Nilsen, D W. T

“…We measured fibrin monomer (FM), soluble fibrin, as a marker of thrombin activity in plasma samples obtained in parallel with the first two routine samples for…”
Get full text

Improvement of serum lipids and blood pressure during intervention with n-3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidaemia by Grundt, H, Nilsen, D W, Hetland, O, Aarsland, T, Baksaas, I, Grande, T, Woie, L

“…To investigate the effect of an omega-3 fatty acid concentrate K85 on serum lipids, lipoproteins, insulin metabolism and blood pressure in subjects with…”
Get more information

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction : Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide by OMLAND, T, AAKVAAG, A, BONARJEE, V. V. S, CAIDAHL, K, LIE, R. T, NILSEN, D. W. T, SUNDSFJORD, J. A, DICKSTEIN, K

“…Elevated plasma levels of atrial natriuretic peptide (ANP) and the N-terminal fragment of the ANP prohormone (N-ANP) are associated with decreased left…”
Get full text

Activated factor XII type A predicts long-term mortality in patients admitted with chest pain by Pönitz, V, Brügger-Andersen, T, Pritchard, D, Grundt, H, Staines, H, Nilsen, D W T

“…We assessed the relation between admission levels of activated factor XII type A (XIIaA), and long-term all-cause and cardiac mortality and recurrent troponin…”
Get full text

Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function by Bonarjee, V. V., Omland, T., Nilsen, D. W., Caidahl, K., Sundsfjord, J. A., Dickstein, K.

“…OBJECTIVES--(a) To assess the relation between plasma concentrations of proatrial natriuretic factor (1-98) and non-invasively derived indices of left…”
Get full text

Inhibitor complexes of the plasma kallikrein–kinin system and outcome prediction in patients following admission for chest pain by PÖNITZ, V., GOVERS‐RIEMSLAG, J. W. P., BRÜGGER‐ANDERSEN, T., Ten CATE, H., NILSEN, D. W. T.

Get full text

Influence of a concentrated ethylester compound of n-3 fatty acids on lipids, platelets and coagulation in patients undergoing coronary bypass surgery by Nilsen, D W, Dalaker, K, Nordøy, A, Osterud, B, Ingebretsen, O C, Lyngmo, V, Almdahl, S, Vaage, J, Rasmussen, K

“…Twenty patients accepted for coronary bypass surgery were randomized to receive either a concentrated ethylester compound of n-3 fatty acids, with a daily dose…”
Get more information

Cardiac troponin T immunoassay on biotin--streptavidin-coated microplates: preliminary performance in acute myocardial infarction by Hetland, O, Goransson, L, Nilsen, D W

“…We have adapted the cardiac troponin T (TnT) immunoassay system (ELISA troponin T, Boehringer Mannheim, Germany), which is based upon streptavidin-biotin…”
Get more information

Lipopolysaccharide induced monocyte thromboplastin synthesis and coagulation responses in patients undergoing coronary bypass surgery after preoperative supplementation with n-3 fatty acids by Nilsen, D W, Almdahl, S M, Svensson, B, Vaage, J, Rasmussen, K, Osterud, B

“…Twenty patients with coronary heart disease (CHD) and elevated serum lipids were randomized into 2 groups of 10 to receive encapsulated preparations of either…”
Get more information

Low levels of dihomo-gamma-linolenic acid are associated with all-cause death in elderly patients with a recent myocardial infarction by Nilsen, D W, Myhre, P L, Kalstad, A A, Schmidt, E B, Arnesen, H, Seljeflot, I

“…Abstract Background In a previous study*, low levels of the omega-6 fatty acid (FA) dihomo-gamma (γ)-linolenic acid (DGLA; C20:3w6), were independently…”
Get full text

Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease by Bønaa, Kaare H, Mannsverk, Jan, Wiseth, Rune, Aaberge, Lars, Myreng, Yngvar, Nygård, Ottar, Nilsen, Dennis W, Kløw, Nils-Einar, Uchto, Michael, Trovik, Thor, Bendz, Bjørn, Stavnes, Sindre, Bjørnerheim, Reidar, Larsen, Alf-Inge, Slette, Morten, Steigen, Terje, Jakobsen, Ole J, Bleie, Øyvind, Fossum, Eigil, Hanssen, Tove A, Dahl-Eriksen, Øystein, Njølstad, Inger, Rasmussen, Knut, Wilsgaard, Tom, Nordrehaug, Jan E

“…In a trial involving over 9000 patients with coronary artery disease who were assigned to receive either contemporary drug-eluting stents or bare-metal stents,…”
Get full text

Changes in EPA and DHA during supplementation with omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial by Myhre, P, Smith, E B, Kalstad, A A, Tveit, S, Laake, K, Smith, P, Nilsen, D W T, Tveit, A, Solheim, S, Arnesen, H, Seljeflot, I

“…Abstract Background In the OMEMI trial, elderly post-MI patients did not achieve reduction in cardiovascular events from supplementation of 1.8g n-3…”
Get full text